LXR and FXR modulators

Details for Australian Patent Application No. 2007333194 (hide)

Owner Exelixis, Inc.

Inventors Gu, Xiao-Hui; Martin, Richard; Stevens Jr., William C.; Xu, Wei; Boren, Brant Clayton; Lu, Shao-Po; Jammalamadaka, Vasu; Mohan, Raju; Wang, Tie-Lin; Busch, Brett B.; Schweiger, Edwin; Xie, Yinong

Agent Davies Collison Cave

Pub. Number AU-A-2007333194

PCT Pub. Number WO2008/073825

Priority 60/869,198 08.12.06 US

Filing date 7 December 2007

Wipo publication date 19 June 2008

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 231/10 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/073825 Priority application(s): WO2008/073825

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333196-Fusion process using an alkali metal metalate

2007333187-Use of PEO-PBO block copolymers in ophthalmic compositions